(1) Background: Colorectal cancer (CRC) is the third most common cancer and the second
leading cause of cancer-related mortality worldwide. Up to 50% of patients with CRC …

Purpose We examine the potential for curative approaches among metastatic breast cancer
(MBC) patients by exploring the recent literature on local ablative therapies like surgery and …

Simple Summary In the present work, we analyzed long-term outcomes of patients with
synchronous oligometastatic (OMD) non-small cell lung cancer (NSCLC) with locally …

Abstract Background and Purpose Stereotactic ablative radiotherapy (SABR) for
oligometastases may improve survival, however concerns about safety remain. To mitigate …

The treatment of head and neck cancers (HNCs) encompasses a complex paradigm
involving a combination of surgery, radiotherapy, and systemic treatment. Locoregional …

Simple Summary Question: Is stereotactic body radiation therapy an effective and safe
treatment option for patients with oligometastatic cancer from a head and neck primary …

Purpose The optimal sequencing of local and systemic therapy for oligometastatic cancer
has not been established. This study retrospectively compared progression-free survival …

In radiation oncology, the paradigm “focal is better” has become the preferred approach in
treating tumors of the brain, lung, spine, liver, and prostate, as well as sites of …

Background Stereotactic body radiotherapy (SBRT) is safe and effective for treatment of
extracranial metastatic disease, but its safety when combined with immune checkpoint …

The paradigm of oligometastatic disease (OMD), characterized by a limited number of
metastases potentially amenable to local therapies, presents unique opportunities and …